Jose Najera JR. has Hematology/oncology as his primary medical specialty. Their primary office is: 104 Nw 31st St in Lawton, Oklahoma.
There is an additional office location, for a total of two, for Jose Najera JR. that can be viewed further down.
They're a part of the: Cancer Centers Of Southwest Oklahoma, Llc medical group which has around 14 members. You can call their office at 580-536-2121 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 2006 (around 18 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.
Jose Najera JR.
Cancer Centers Of Southwest Oklahoma, Llc
104 Nw 31st St
Lawton, Oklahoma 73505
580-536-2121
Phone: 580-536-2121
Enter a starting address:
Medical School: Sorry, his university is not listed
Graduation Year: 2006
The Primary Medical Specialty for Jose Najera JR. is listed as: Hematology/oncology
Approximate Years of Experience: 18
PAC (PECOS ID)#: 2961648274
NPI #: 1760667851
NPI Created On: 01/08/2008
NPI Last Updated Listed as: 03/03/2016
Primary Taxonomy Code: 390200000X
Listed Gender: Male
Forms of insurance accepted by include, but are not limited to:
They are listed as accepting new patients.
Languages spoken by staff include: English.
Services and Procedures include:
Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.
Payments Total: $12
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 788655185
Being Disputed:: No
Product Related: Yes
Drug or Biological: Biological
Product Category #1: Oncology
Name of Drug #1: DARZALEX
Open Associated Drug #1: 57894-502-05
Drug or Biological: Biological
Product Category #2: Oncology
Name Of Drug #2:: IMBRUVICA
Associated Drug #2: 57962-140-09
Payments Total: $19
Number of Payments:: 1
Form of Payment: In-kind items and services
Record ID:: 781013381
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: ONCOLOGY
Name of Drug #1: IMBRUVICA
Open Associated Drug #1: 57962-420-28
Payments Total: $20
Number of Payments:: 1
Form of Payment: In-kind items and services
Record ID:: 781013383
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: ONCOLOGY
Name of Drug #1: IMBRUVICA
Open Associated Drug #1: 57962-420-28
Payments Total: $12
Number of Payments:: 1
Form of Payment: In-kind items and services
Record ID:: 781013385
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: ONCOLOGY
Name of Drug #1: IMBRUVICA
Open Associated Drug #1: 57962-420-28
Payments Total: $16
Number of Payments:: 1
Form of Payment: In-kind items and services
Record ID:: 781013387
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: ONCOLOGY
Name of Drug #1: IMBRUVICA
Open Associated Drug #1: 57962-420-28
Payments Total: $93
Number of Payments:: 1
Form of Payment: In-kind items and services
Record ID:: 795278659
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: ONCOLOGY
Name of Drug #1: VENCLEXTA
Open Associated Drug #1: 0074-0576-22
Payments Total: $16
Number of Payments:: 1
Form of Payment: In-kind items and services
Record ID:: 795278653
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: ONCOLOGY
Name of Drug #1: VENCLEXTA
Open Associated Drug #1: 0074-0576-22
Payments Total: $13
Number of Payments:: 1
Form of Payment: In-kind items and services
Record ID:: 795278665
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: ONCOLOGY
Name of Drug #1: VENCLEXTA
Open Associated Drug #1: 0074-0576-22
Payments Total: $16
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 818579437
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: CYRAMZA
Open Associated Drug #1: 0002-7669-01
Drug or Biological: Drug
Product Category #2: Oncology
Name Of Drug #2:: RETEVMO
Associated Drug #2: 0002-2980-60
Payments Total: $14
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 818579439
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: VERZENIO
Open Associated Drug #1: 0002-6216-54
Drug or Biological: Drug
Product Category #2: Oncology
Name Of Drug #2:: RETEVMO
Associated Drug #2: 0002-2980-60
1. Cancer Centers Of Southwest Oklahoma, Llc
2110 Duncan Regional Loop
Duncan, OK 73533
Group Members: 14
Phone: 580-536-2121
Enter a starting address:
104 Nw 31st St
Lawton, OK
Cancer Centers Of Southwest Oklahoma, Llc
104 Nw 31st St
Lawton, OK
Cancer Centers Of Southwest Oklahoma, Llc
104 Nw 31st St
Lawton, OK
Cancer Centers Of Southwest Oklahoma, Llc
104 Nw 31st St
Lawton, OK
Cancer Centers Of Southwest Oklahoma, Llc
104 Nw 31st St
Lawton, OK
Cancer Centers Of Southwest Oklahoma, Llc
104 Nw 31st St
Lawton Ok 73505-6100
Cancer Centers Of Southwest Oklahoma, Llc
Hematology/oncology
1200 E Broadway St
Altus Ok 73521-5702
Cancer Centers Of Southwest Oklahoma, Llc
Hematology/oncology
104 Nw 31st St
Lawton Ok 73505-6100
Cancer Centers Of Southwest Oklahoma, Llc
Nurse Practitioner
2110 Duncan Regional Loop
Duncan Ok 73533-1568
Cancer Centers Of Southwest Oklahoma, Llc
Nurse Practitioner
104 Nw 31st St
Lawton Ok 73505-6100
Cancer Centers Of Southwest Oklahoma, Llc
Medical Oncology
2110 Duncan Regional Loop
Duncan Ok 73533-1568
Cancer Centers Of Southwest Oklahoma, Llc
Medical Oncology
View all 14 members of Cancer Centers Of Southwest Oklahoma, Llc medical group